Literature DB >> 35699754

Reversal of Fetal Heart Block in Antibody-Positive Mother After Hydroxychloroquine and Dexamethasone.

Mehar Hoda1, William Scott2, Kavita Sharma2, Elaine Duryea3, Catherine Ikemba2.   

Abstract

Maternal autoantibody-related complete heart block in the fetus is considered irreversible. During prenatal care for a 25-year-old nulliparous Hispanic woman with newly diagnosed nephrotic-range proteinuria and positive anti-nuclear antigen antibody, complete fetal heart block with a ventricular rate of 60 beats per minute was detected on a fetal echocardiogram at 28-week gestation. A small pericardial effusion and ascites were noted consistent with fetal hydrops. Dexamethasone and hydroxychloroquine were initiated. Fetal rhythm improved to Mobitz type 1 second-degree heart block, with a ventricular rate of 91 beats per minute. The fetus was born prematurely at 34-week gestation with second-degree heart block which improved to first-degree heart block prior to hospital discharge. First-degree heart block persisted at 2 years of age with a P-R interval of 185 ms. Transplacental treatment with dexamethasone and hydroxychloroquine was associated with sustained reversal of complete heart block to sinus rhythm.
© 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Entities:  

Keywords:  Anti-Ro antibody; Atrioventricular block; Heart block; Hydroxychloroquine; Maternal lupus

Year:  2022        PMID: 35699754     DOI: 10.1007/s00246-022-02945-6

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  19 in total

1.  Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus.

Authors:  Peter M Izmirly; Amit Saxena; Mimi Y Kim; Dan Wang; Sara K Sahl; Carolina Llanos; Deborah Friedman; Jill P Buyon
Journal:  Circulation       Date:  2011-10-03       Impact factor: 29.690

2.  Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30 years.

Authors:  Edgar T Jaeggi; Robert M Hamilton; Earl D Silverman; Samuel A Zamora; Lisa K Hornberger
Journal:  J Am Coll Cardiol       Date:  2002-01-02       Impact factor: 24.094

3.  Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients.

Authors:  Håkan Eliasson; Sven-Erik Sonesson; Gurleen Sharland; Fredrik Granath; John M Simpson; Julene S Carvalho; Hana Jicinska; Viktor Tomek; Joanna Dangel; Paulo Zielinsky; Maria Respondek-Liberska; Matthias W Freund; Mats Mellander; Joaquim Bartrons; Helena M Gardiner
Journal:  Circulation       Date:  2011-10-10       Impact factor: 29.690

4.  Fluorinated steroids do not improve outcome of isolated atrioventricular block.

Authors:  N W E Van den Berg; M G Slieker; I M van Beynum; C M Bilardo; D de Bruijn; S A Clur; J M J Cornette; I M E Frohn-Mulder; M C Haak; K E H van Loo-Maurus; G T R Manten; A B M H Rackowitz; L A J Rammeloo; A Reimer; M E B Rijlaarsdam; M W Freund
Journal:  Int J Cardiol       Date:  2016-09-30       Impact factor: 4.164

Review 5.  Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies.

Authors:  Antonio Brucato; Rolando Cimaz; Roberto Caporali; Véronique Ramoni; Jill Buyon
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

6.  Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry.

Authors:  J P Buyon; R Hiebert; J Copel; J Craft; D Friedman; M Katholi; L A Lee; T T Provost; M Reichlin; L Rider; A Rupel; S Saleeb; W L Weston; M L Skovron
Journal:  J Am Coll Cardiol       Date:  1998-06       Impact factor: 24.094

Review 7.  Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome.

Authors:  Kateri Levesque; Nathalie Morel; Alice Maltret; Gabriel Baron; Agathe Masseau; Pauline Orquevaux; Jean-Charles Piette; Francois Barriere; Jérome Le Bidois; Laurent Fermont; Olivier Fain; Arnaud Theulin; Francois Sassolas; Philippe Pezard; Zahir Amoura; Gaëlle Guettrot-Imbert; Delphine Le Mercier; Sophie Georgin-Lavialle; Christophe Deligny; Eric Hachulla; Luc Mouthon; Philippe Ravaud; Elisabeth Villain; Damien Bonnet; Nathalie Costedoat-Chalumeau
Journal:  Autoimmun Rev       Date:  2015-08-15       Impact factor: 9.754

8.  Perinatal outcome of fetal atrioventricular block: one-hundred-sixteen cases from a single institution.

Authors:  Lilian M Lopes; Gláucia Maria Penha Tavares; Ana Paula Damiano; Marco Antônio Borges Lopes; Vera Demarchi Aiello; Regina Schultz; Marcelo Zugaib
Journal:  Circulation       Date:  2008-09-02       Impact factor: 29.690

9.  First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry).

Authors:  Micaela Fredi; Laura Andreoli; Beatrice Bacco; Tiziana Bertero; Alessandra Bortoluzzi; Silvia Breda; Veronica Cappa; Fulvia Ceccarelli; Rolando Cimaz; Salvatore De Vita; Emma Di Poi; Elena Elefante; Franco Franceschini; Maria Gerosa; Marcello Govoni; Ariela Hoxha; Andrea Lojacono; Luca Marozio; Alessandro Mathieu; Pier Luigi Meroni; Antonina Minniti; Marta Mosca; Marina Muscarà; Melissa Padovan; Matteo Piga; Roberta Priori; Véronique Ramoni; Amelia Ruffatti; Chiara Tani; Marta Tonello; Laura Trespidi; Sonia Zatti; Stefano Calza; Angela Tincani; Antonio Brucato
Journal:  Front Cardiovasc Med       Date:  2019-02-28

10.  Outcome of Antibody-Mediated Fetal Heart Disease With Standardized Anti-Inflammatory Transplacental Treatment.

Authors:  Wadi Mawad; Lisa Hornberger; Bettina Cuneo; Marie-Josée Raboisson; Anita J Moon-Grady; Jane Lougheed; Karim Diab; Julia Parkman; Earl Silverman; Edgar Jaeggi
Journal:  J Am Heart Assoc       Date:  2022-01-08       Impact factor: 6.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.